1. Recalibration of thinking about adrenocortical function assessment: how the ‘random’ cortisol relates to the short synacthen test results
- Author
-
Mark Livingston, Adrian H. Heald, Samantha Dolan, Adam Robinson, Maria Michaelidou, Lauren Morris, Anthony A. Fryer, Ghasem Yadegarfar, Peter J Trainer, Christopher J. Duff, and Asma Naseem
- Subjects
endocrine system ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Corticosteroid treatment ,pituitary ,RC0254 ,Time of day ,RA0421 ,Internal medicine ,Adrenal insufficiency ,Medicine ,Short synacthen test ,Adrenal function ,RM695 ,Cortisol level ,short synacthen test ,business.industry ,steroid ,Original Articles ,medicine.disease ,random serum cortisol ,Endocrinology ,adrenal insufficiency ,Cardiology and Cardiovascular Medicine ,business ,hormones, hormone substitutes, and hormone antagonists ,Serum cortisol ,Glucocorticoid ,RC ,medicine.drug - Abstract
Background The short synacthen test (SST) is the most commonly performed investigation to assess adrenal function. Appropriate criteria for when an SST is performed are subject to debate. We investigated how random serum cortisol levels relate to SST response. Methods We examined random cortisol measurements taken between 04.40–23.55 p.m. results of SST baseline and 30-/60-min cortisol performed over 12 months (225 SSTs) at Salford Royal Hospital. Serum cortisol was measured on the Siemens Centaur Analyser. A 30–60-min cortisol concentration of ≥450 nmol/L defined a pass; 350–449 nmol/L defined borderline. Results Patients only proceeded to SST if random cortisol was
- Published
- 2021
- Full Text
- View/download PDF